CN Patent

CN102264227A — C5aR拮抗剂

Assigned to Chemocentryx Inc · Expires 2011-11-30 · 14y expired

What this patent protects

本发明提供了作为C5a受体调节剂的化合物。所述化合物是取代的哌啶，可用在用于治疗涉及C5a受体之病理性活化之疾病和病症的药物组合物和方法中。

USPTO Abstract

本发明提供了作为C5a受体调节剂的化合物。所述化合物是取代的哌啶，可用在用于治疗涉及C5a受体之病理性活化之疾病和病症的药物组合物和方法中。

Drugs covered by this patent

Patent Metadata

Patent number
CN102264227A
Jurisdiction
CN
Classification
—
Expires
2011-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Chemocentryx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.